(Q39215897)

10 September 2017

Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation (English)

1 reference

10 September 2017

1 reference

Hongbo Wang

1

1 reference

10 September 2017

Guang Cheng

2

1 reference

10 September 2017

Yuan Du

3

1 reference

10 September 2017

Liang Ye

4

1 reference

10 September 2017

Wenzhong Chen

5

1 reference

10 September 2017

Leiming Zhang

6

1 reference

10 September 2017

Tian Wang

7

1 reference

10 September 2017

Jingwei Tian

8

1 reference

10 September 2017

Fenghua Fu

9

1 reference

10 September 2017

4 January 2013

1 reference

Molecular Medicine Reports

10 September 2017

1 reference

10 September 2017

7

1 reference

10 September 2017

3

1 reference

10 September 2017

947-952

1 reference

Liposomal paclitaxel formulations

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Advances of paclitaxel formulations based on nanosystem delivery technology

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Impact of albumin on drug delivery--new applications on the horizon.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Role for basophils in systemic anaphylaxis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Microtubules and resistance to tubulin-binding agents

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Lipid formulations of amphotericin B as first-line treatment of zygomycosis

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Novel formulations of taxanes: a review. Old wine in a new bottle?

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Microtubules as a target for anticancer drugs

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Rapid and accurate determination of the median lethal dose (LD50) and its error with a small computer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Taxol: a history of pharmaceutical development and current pharmaceutical concerns

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Liposomal doxorubicin (Doxil).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Clinical toxicities encountered with paclitaxel (Taxol).

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3597461

Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20

21 August 2018

1 reference

12 December 2020

Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis

1 reference

12 December 2020

Taxol-based combination chemotherapy and other in vivo preclinical antitumor studies

1 reference

12 December 2020

Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study

1 reference

12 December 2020

Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel

1 reference

12 December 2020

New taxanes in development

1 reference

12 December 2020

Identifiers

DOI

10.3892/MMR.2013.1264

1 reference

10 September 2017

1 reference

10 September 2017

PubMed publication ID

23291923

1 reference